



CASE REPORT Year : 2018 | Volume : 39 | Issue : 2 | Page : 133-135

Measles, mumps, and rubella vaccine in genital warts: A case report of two patients



Dilip Meena, Shilpi Sharma, Payal Chauhan

Department of Dermatology and Venereology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India





Date of Web Publication 7-Dec-2018

Correspondence Address:

Dr. Dilip Meena

Department of Dermatology and Venereology, All India Institute of Medical Sciences, Rishikesh - 249 201, Uttrakhand

India

Source of Support: None, Conflict of Interest: None Check

DOI: 10.4103/ijstd.IJSTD_44_16



Abstract

Genital warts have a big psychological impact on the affected individuals, as the treatment requires time and multiple sessions at a time. They can also increase the chances of acquiring other sexually transmitted diseases. Various treatment options are available including the topical application of imiquimod, podophyllin, trichloroacetic acid application, cryotherapy, and radiofrequency cautery. However, all of these require multiple sessions, and chances of recurrences are high. Some of them also have multiple local side effects as burning, irritation, erythema, and swelling. Overall genital warts represent a frustrating challenge for both patients and physicians. Intralesional immunotherapy has shown promising efficacy in the treatment of warts including the following: Bacille Calmette–Guerin vaccine, candida antigen, Mw vaccine, and measles, mumps, and rubella (MMR) vaccine. We report the two cases of genital warts, who had an excellent response with intralesional MMR vaccine.

Keywords: Genital warts, immunotherapy, intralesional, measles, mumps and rubella vaccine

How to cite this article:

Meena D, Sharma S, Chauhan P. Measles, mumps, and rubella vaccine in genital warts: A case report of two patients. Indian J Sex Transm Dis 2018;39:133-5

How to cite this URL:

Meena D, Sharma S, Chauhan P. Measles, mumps, and rubella vaccine in genital warts: A case report of two patients. Indian J Sex Transm Dis [serial online] 2018 [cited 2020 Sep 24];39:133-5. Available from: http://www.ijstd.org/text.asp?2018/39/2/133/247086

Introduction

Case Report

Figure 1: Multiple verrucous papules and plaques with exophytic growth on glans and prepuce



Click here to view

Figure 2: Significant flattening of lesions at 3 weeks (after the single session)



Click here to view

Figure 3: Complete clearance at 6 weeks (after the second session)



Click here to view

Figure 4: Verrucous papules over the penile shaft, prepuce, and glans



Click here to view

Figure 5: Almost complete clearance at 3 weeks (After a single session)



Click here to view

Discussion

Conclusion

References

1.

Rivera A, Tyring SK. Therapy of cutaneous human papillomavirus infections. Dermatol Ther 2004;17:441-8. 2.

Nofal A, Nofal E. Intralesional immunotherapy of common warts: Successful treatment with mumps, measles and rubella vaccine. J Eur Acad Dermatol Venereol 2010;24:1166-70. 3. Mycobacterium w vaccine for the treatment of anogenital warts: An open-label pilot study. J Eur Acad Dermatol Venereol 2008;22:1089-93.

Gupta S, Malhotra AK, Verma KK, Sharma VK. Intralesional immunotherapy with killedw vaccine for the treatment of anogenital warts: An open-label pilot study. J Eur Acad Dermatol Venereol 2008;22:1089-93. 4.

Clifton MM, Johnson SM, Roberson PK, Kincannon J, Horn TD. Immunotherapy for recalcitrant warts in children using intralesional mumps or candida antigens. Pediatr Dermatol 2003;20:268-71. 5.

Kus S, Ergun T, Gun D, Akin O. Intralesional tuberculin for the treatment of refractory warts. J Eur Acad Dermatol Venereol 2005;19:515-6. 6.

Johnson SM, Roberson PK, Horn TD. Intralesional injection of mumps or candida skin test antigens: A novel immunotherapy for warts. Arch Dermatol 2001;137:451-5. 7.

Goihman-Yahr M, Goldblum OM. Immunotherapy and warts: A point of view. Clin Dermatol 2008;26:223-5.